Page 990«..1020..989990991992..1,0001,010..»

Unexpected Growth Seen in Stem Cell Characterization and Analysis Tool Market from 2020 to 2025 – Bulletin Line

Posted: June 4, 2020 at 9:30 am

The latest report pertaining to Stem Cell Characterization and Analysis Tool Market now available with Market Study Report, LLC, provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.

.

Request a sample Report of Stem Cell Characterization and Analysis Tool Market at:https://www.marketstudyreport.com/request-a-sample/2679261?utm_source=bulletinline&utm_medium=ADS

The latest report on the Stem Cell Characterization and Analysis Tool market contains a detailed analysis of this marketplace and entails information about various industry segmentations. According to the report, the market is presumed to amass substantial revenue by the end of the forecast duration while expanding at decent growth rate.

Details regarding the industry size, remuneration potential, and volume share are compiled in the report. It further lists out the drivers and challenges that will impact the growth of Stem Cell Characterization and Analysis Tool market during the estimated timeframe.

The Stem Cell Characterization and Analysis Tool market with respect to the geographical terrain:

Ask for Discount on Stem Cell Characterization and Analysis Tool Market Report at:https://www.marketstudyreport.com/check-for-discount/2679261?utm_source=bulletinline&utm_medium=ADS

Additional highlights from the Stem Cell Characterization and Analysis Tool market share report are enlisted below:

Table of Contents:

Executive Summary: It includes key trends of the Stem Cell Characterization and Analysis Tool market share related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the Stem Cell Characterization and Analysis Tool market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Stem Cell Characterization and Analysis Tool market.

Market Segments: This part of the report discusses about product type and application segments of the Stem Cell Characterization and Analysis Tool market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

For More Details On this Report:https://www.marketstudyreport.com/reports/global-stem-cell-characterization-and-analysis-tool-market-2020-by-company-regions-type-and-application-forecast-to-2025

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Stem Cell Characterization and Analysis Tool Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

Chapter 4: Stem Cell Characterization and Analysis Tool Market, By Region

Chapter 5: Company Profile

Business Overview

Financial Data

Product Landscape

Strategic Outlook

SWOT Analysis

Related Reports:

1. Global Sterile Vial Adaptor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025The Sterile Vial Adaptor Market Report offer the complete scenario of the industry and valuation of upcoming Trends for future market. It also gives the analytic of enduring growth factor, trends and statistic of Sterile Vial Adaptor Market industry. The Sterile Vial Adaptor Market has been outlined by overall information and analysis.Read More: https://www.marketstudyreport.com/reports/global-sterile-vial-adaptor-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

2. Global Protective Medical Gowns Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Protective Medical Gowns Market report starts from illustration of Industry Chain structure, and portrays industry condition, at that point investigations advertise size and figure of Protective Medical Gowns by item, district and application, likewise, this report presents showcase rivalry circumstance among the merchants profile, plus, advertise value examination and esteem chain highlights are canvassed in this report.Read More: https://www.marketstudyreport.com/reports/global-protective-medical-gowns-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Read More Reports On: https://www.marketwatch.com/press-release/51-growth-for-extracorporeal-shock-wave-lithotripter-market-size-raising-to-usd-470-million-by-2025-2020-03-19?tesla=y

Read More Reports On: https://www.marketwatch.com/press-release/at-38-cagr-hazardous-area-signaling-devices-market-size-set-to-register-2170-million-usd-by-2025-2020-03-23?tesla=y

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

See the original post:
Unexpected Growth Seen in Stem Cell Characterization and Analysis Tool Market from 2020 to 2025 - Bulletin Line

Posted in Stem Cell Research | Comments Off on Unexpected Growth Seen in Stem Cell Characterization and Analysis Tool Market from 2020 to 2025 – Bulletin Line

Some types of prostate cancer may not be as aggressive as originally thought – Mirage News

Posted: June 4, 2020 at 9:30 am

UCLA

Dr. Amar Kishan

FINDINGS

Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group known as Gleason grade group 5 and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences. The findings may affect how people are treated for the disease.

One subtype, which accounts for about 15% of the grade group 5 cancers, has highly aggressive features and is associated with much worse outcomes than the other subtypes. Another, which makes up about 20% of the tumors, appears to be much less aggressive and may not require intensified and aggressive treatments. Traditionally, all tumors in Gleason grade group 5 have been treated in the same way.

BACKGROUND

Prostate cancer is the leading solid-tumor cancer among men in the United States and a major cause of morbidity globally. While early-stage, localized prostate cancer is curable, current treatments dont always work for everyone. To find out why standard treatment may work for some and not others, the UCLA researchers looked at tumors in the Gleason grade group 5 subset of prostate cancer. These tumors are at the highest risk to fail standard treatment, leading to metastasis and death. The researchers thought that studying the gene expression the unique signature of each cancer cell in these tumors might provide insight into how to make treatments more personalized for each patient.

METHOD

The researchers first analyzed data from more than 2,100 Gleason grade group 5 tumors, looking at how the genetic blueprints differed among the tumors. They identified distinct clusters of subgroups and validated their findings by analyzing an additional cohort of more than 1,900 Gleason grade group 5 prostate cancers.

IMPACT

By using the genetic information from tumors in men with prostate cancer, physicians hope to one day create more personalized treatments based on the actual characteristics of the cancer. This information will help optimize quality of life and avoid overtreating subgroups of men who may not need aggressive treatments.

AUTHORS

The studys lead author is Dr. Amar Kishan, an assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center. The co-senior authors are Dr. Joanne Weidhaas, a professor of radiation oncology and director of translational research at the Geffen School of Medicine, and Paul Boutros, a professor of urology and human genetics and director of cancer data science for the Jonsson Cancer Center. Boutros is also a member of the UCLA Institute of Urologic Oncology and the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA. Other UCLA authors include David Elashoff, Dr. Rob Reiter and Dr. Matthew Rettig.

JOURNAL

The study was published in the journal European Urology.

FUNDING

The research was funded in part by an award from the American Society for Radiation Oncology and the Prostate Cancer Foundation, the Radiological Society of North America, and the National Institutes of Health.

Go here to see the original:
Some types of prostate cancer may not be as aggressive as originally thought - Mirage News

Posted in Stem Cell Research | Comments Off on Some types of prostate cancer may not be as aggressive as originally thought – Mirage News

Human Mesenchymal Stem Cells (hMSC) Market investigated in the latest research – WhaTech Technology and Markets News

Posted: June 4, 2020 at 9:30 am

Human Mesenchymal Stem Cells (hMSC) Market Sales 2020-2026

Worldwide Human Mesenchymal Stem Cells (hMSC) Market Report 2020-2026 is a systematic and insightful compilation of valuable evaluations of Human Mesenchymal Stem Cells (hMSC) market and relevant aspects. The report offers an in depth exploration of the market and its scope, trends, structure, production, profitability and maturity.

The precise evaluation of market size, share, revenue, sales volume, demand, and rate of growth involved within the report drive investors, industry experts, researchers, also as novice and well-established market players to grasp the general Human Mesenchymal Stem Cells (hMSC) market structure.

Report: calibreresearch.com/report/est-sample The Human Mesenchymal Stem Cells (hMSC) market report also delivers an in-depth analysis of the emerging industry trends along side the restraints, key players, and opportunities within the Human Mesenchymal Stem Cells (hMSC) market to supply worthwhile insights also as a gift scenario for generating right decision.

Moreover, the new report on the Human Mesenchymal Stem Cells (hMSC) industry covers the prominent vendors within the universal market alongside SWOT analysis, fiscal overview and major developments. The world Human Mesenchymal Stem Cells (hMSC) Market report is considered as a detailed investigation of the respective market that will provide key solutions for establishment of profit-driven business strategies.

It is helpful for offering details about futuristic Human Mesenchymal Stem Cells (hMSC) industry trends and in-depth assessment of the international industry. It permits you to determine remarkable challenges and risk factors alongside major opportunities available in the world Human Mesenchymal Stem Cells (hMSC) market.

This report also exhibits the whole historical and current status of the Human Mesenchymal Stem Cells (hMSC) Market worldly. Apart from this, the report on the Human Mesenchymal Stem Cells (hMSC) industry also represents the graphical representation of the upcoming Human Mesenchymal Stem Cells (hMSC) Market infrastructure and the Compound Annual Growth Rate (CAGR) in detail.

Report: calibreresearch.com/report/for-buying

The report on the Human Mesenchymal Stem Cells (hMSC) market is an exclusive and deep study which delivers a comprehensive overview of the industry contains the recent trends and future proportions of the Human Mesenchymal Stem Cells (hMSC) market in terms of product and services. Meanwhile, this report offers a professional research study on the Human Mesenchymal Stem Cells (hMSC) market so as to guage the remarkable vendors by calibrating all the relevant products or services to know the positioning of the key players within the Human Mesenchymal Stem Cells (hMSC) market worldly.

Leading companies reviewed in the Human Mesenchymal Stem Cells (hMSC) report are: PromoCell ThermoFisher KURABO Lifeline Cell Technology Merck The Human Mesenchymal Stem Cells (hMSC) Market report is segmented into following categories: The product segment of the report offers product market information such as demand, supply and market value of the product. The application of product in terms of USD value is represented in numerical and graphical format for all the major regional markets.

The Human Mesenchymal Stem Cells (hMSC) market report is segmented into Type by following categories; Umbilical Cord Matrix hMSC Bone Marrow hMSC Adipose Tissue hMSC Other The Human Mesenchymal Stem Cells (hMSC) market report is segmented into Application by following categories; Medical Application Research Other Applications

Report: calibreresearch.com/report/est-sample

The world Human Mesenchymal Stem Cells (hMSC) marketing research report offers an in depth summary of the foremost desirable factors and informative details about the universal industry. Moreover, the study provides an in-depth summary and forecast of the worldwide Human Mesenchymal Stem Cells (hMSC) market on the idea of several segments.

This report also delivers Human Mesenchymal Stem Cells (hMSC) market size and predicted estimations from the year 2020 to 2026 concerning various topological regions including Europe, North America, the center East and Africa, and South America. The research study on the Human Mesenchymal Stem Cells (hMSC) Market is a valuable source of guidance for world customers as it will rapidly fulfil their requirement and speed up their business growth.

It is an advantageous document for both existing industries manufactures including end-user industries, experts, managers, stakeholders and new entrants. We have designed this world Human Mesenchymal Stem Cells (hMSC) Market report in a deeply understandable format so that anyone can grasp each and every aspect related to the respective industry.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow this link:
Human Mesenchymal Stem Cells (hMSC) Market investigated in the latest research - WhaTech Technology and Markets News

Posted in Stem Cell Research | Comments Off on Human Mesenchymal Stem Cells (hMSC) Market investigated in the latest research – WhaTech Technology and Markets News

Is COVID-19 actually a disease of the blood vessels? New research could help explain odd symptoms from strokes to purple toes – The Flamborough Review

Posted: June 4, 2020 at 9:30 am

When people first started to get sick, the focus was on those organs, he said. But that started to shift as health workers saw first thousands and now millions of patients with COVID-19, including many whose symptoms didnt fit the typical profile of a respiratory disease.

Patients were showing up with blood clots, strokes, brain swelling and, on the more mild end of the spectrum, toe pain.

The authors approached their study like a crime scene investigation, trying to figure out why all these strange symptoms were happening, Li said.

And looking at these tissues, what we found was that the respiratory virus had not only infected the lung, but the virus had also made a beeline for the cells lining blood vessels, he said.

When those endothelial cells are damaged by the virus, it makes the blood more likely to clot, he said.

The studys authors saw from close-up pictures that the virus had moved from the air sacs of the lungs, infecting directly into the blood vessel cells.

The cells were being destroyed from the inside out, unlike when someone has high cholesterol and theyre damaged from the outside. There was emergency blood vessel growth as they divided to get more blood flow, which can lead to clots. The immune system trying to clear the virus can also cause inflammation and clotting.

So this is sort of three strikes that we saw in our study to help explain this clotting, Li said.

The damage was found in vast areas of the lungs at the same time, he added, and not just a few pockets.

Thats not something that we normally see with respiratory virus, and it seems to be unique to COVID-19.

His study also looked at the lungs of people who had died from H1N1, and found they had nine times fewer blood clots in the lungs.

An April paper in The Lancet also showed damage to endothelial cells in several areas of the body including the lungs, heart, kidneys, liver and intestines of COVID-19 patients.

Isaac Bogoch, an infectious diseases specialist at the University of Toronto and University Health Network, said he hasnt seen any COVID toes yet but has seen some vascular symptoms such as blood clots, in patients at Toronto General. Its not uncommon for diseases to have an inflammatory component, he said.

Cat-scratch disease, a bacterial infection caused by cats who turn on their owners, is one example.

But its important to remember that most people dont get a blood clot, he said, adding that within hospitals doctors are still seeing blood clots in some individuals but certainly not most individuals.

Lis research might help explain, though, why older people and those with conditions like diabetes or heart disease tend to have worse outcomes. Their blood vessels are already more vulnerable.

And it does open some new doors of thinking about treatments, Li said.

Blood thinners could be one example. There are also ongoing clinical trials looking at dilating the blood vessels with nitric oxide, and stem cell treatments to regenerate the cells. Its also important to remember that maintaining a nutritious diet can help keep blood vessels healthy, he added.

A New England Journal of Medicine paper from early May looked at outcomes of 8,910 patients across Asia, North America and Europe. It found that the use of either ACE inhibitors (medications that dilate blood vessels) or statins (drugs that help lower cholesterol) was associated with better survival. But the study could not prove a cause-and-effect relationship as it was not a randomized, controlled trial.

Researchers still dont know why COVID-19 is so much worse for some seemingly healthy people than for others, at what point the blood vessel damage starts to occur, and why blood vessels are affected in some parts of the body but not others.

The unknowns of this disease still far outnumber the knowns, so it will take time to construct the full picture of how the SARS- COV2 virus actually causes COVID-19, Li said. But blood clotting could help explain COVID toes, as well as more serious symptoms like strokes.

Multisystem inflammatory syndrome, which has been diagnosed in a small number of kids and teens who test positive for COVID-19 or antibodies that suggest they had it, may also be connected to blood vessel damage, he added.

Luckily, Jake didnt experience any severe issues, but he did have an on-and-off fever. Hes the only one in his family who had the COVID toes. His dad, Jeff, said he had the heavy, heavy chest and didnt feel like he had a full set of lungs but was lucky it didnt get more serious. His younger sister Ella had a low-grade fever for several days, but his mom and two other siblings didnt notice anything out of the ordinary.

They were told by doctors, who diagnosed Jakes toes through virtual visits, to assume they all had it, said Jeff. And their family shows the wide range of effects the disease can have on different people.

Weve got four kids, so we have a larger sample size, he said with a laugh. Weve shared air amongst us and 50 per cent had issues and 50 per cent didnt.

The Reymer family was initially told not to go for testing and just to keep self-isolating. By the time Jake and his father did get tested weeks later, when it opened up to people with more unusual symptoms, they were both negative, possibly because the virus had already cleared from their systems. The province is now urging anyone with even one mild symptom, including loss of taste and smell, and COVID toes, to get a test, as well as asymptomatic people who work in front-line jobs or think they may have been exposed.

Jake is now back to playing basketball and walking around the neighbourhood. Hes feeling good and his toes seem to be improving. But theyre still purple.

They havent shown any real signs of resolving, he said.

Im 100 per cent, its just my toes still arent normal.

May Warren is a Toronto-based breaking news reporter for the Star. Follow her on Twitter: @maywarren11

See the article here:
Is COVID-19 actually a disease of the blood vessels? New research could help explain odd symptoms from strokes to purple toes - The Flamborough Review

Posted in Stem Cell Research | Comments Off on Is COVID-19 actually a disease of the blood vessels? New research could help explain odd symptoms from strokes to purple toes – The Flamborough Review

Orange Nutrition: Benefits, Calories, Warnings and Recipes – LIVESTRONG.COM

Posted: June 4, 2020 at 9:27 am

When eaten as part of a healthy diet, oranges can benefit your skin, heart and digestive health. The refreshing citrus fruit is famously known for its high levels of vitamin C, an antioxidant that may help shorten the duration of colds and is linked to a lower risk of cancer.

Oranges supply more than 100 percent of your Daily Value of vitamin C, which can help shorten colds.

Image Credit: LIVESTRONG.com Creative

Delicious eaten raw, slightly frozen or blended into a smoothie, this fruit is an easy way to make your diet more nutritious. If you love to grill or roast meat, a squeeze of orange can also double as a healthy tenderizer.

Oranges have the added benefit of being convenient to toss in a lunch bag for a quick snack or part of a meal.

Orange Nutrition Facts

One large orange is equal to a single serving. One large orange contains:

Orange Macros

Vitamins, Minerals and Other Micronutrients

Health Benefits of Oranges

Oranges can improve the health of your skin, heart and digestive system. Their high levels of vitamin C may contribute to healthy collagen levels, shorter colds and lower risk of cancer.

1. They're Linked to Improved Skin Health

The vitamin C in oranges plays a number of protective roles in the body, including keeping your skin healthy and youthful. One large orange provides more than your entire DV of this nutrient.

Vitamin C plays a key role in the production of collagen, which is the structural protein that gives skin elasticity. The vitamin C content in your skin and your body's production of collagen naturally decline as you age, according to Oregon State University.

This decrease in collagen contributes to wrinkles. It may also cause health issues like weakening muscles, joint pain, osteoarthritis or even gastrointestinal problems due to the thinning of your digestive tract lining, per the Cleveland Clinic. After aging, a poor diet is the most common cause of low collagen levels in the body.

Although you may think of skin health as largely involving topical treatments, dietary intake of healthy nutrients is generally linked to improved appearance of the skin. Nutrient supplementation improved both the perception of skin health and actual skin health including appearance, roughness, wrinkling and elasticity in a March 2015 review in the journal Nutrition Research.

More research is needed to determine the effect of nutrient-rich foods and vitamin C on skin appearance. However, antioxidant-rich foods like oranges generally seem to have a protective effect, per the Mayo Clinic.

Vitamin C also helps to repair wounds and even affects your oral health. In fact, vitamin C may contribute to a lower risk of periodontal (gum) disease and can improve gingival bleeding in gingivitis, according to a July 2019 review in the International Journal of Environmental Research and Public Health.

"Vitamin C benefits your gum health because its antioxidant properties help to renew, rebuild and constantly keep tissue healthy," says Natalie Allen, RD, clinical assistant professor of biomedical sciences at Missouri State University.

A large orange contains 4.4 grams of fiber, which is 18 percent of the DV. Fiber is an essential part of a healthy diet, according to the Mayo Clinic. A high-fiber diet:

Oranges are filled with soluble fiber, which is also found in apples, oats, peas, beans and carrots. "The soluble fiber in oranges is very helpful in lowering cholesterol and keeping your gastrointestinal tract healthy, and also slows down the digestion of food," Allen says.

While too many starchy foods can lead to constipation (and too much sugar or processed food can lead to diarrhea), fiber keeps your digestive system running smoothly. Soluble fiber can reduce gas and bloating, and changes into a gel-like substance during digestion, which makes stool softer and bulkier for easier excretion, per Harvard Medical School.

Oranges are one type of food certified as heart-healthy by the American Heart Association. Certified foods must be a good source (provide at least 10 percent DV per serving) of one more of these six nutrients: vitamin A, vitamin C, iron, calcium, protein and dietary fiber. Oranges qualify due to their fiber and vitamin C content.

Are You Getting Enough Fiber?

Track your macros by logging your meals on the MyPlate app. Download now to fine-tune your diet today!

Americans generally don't get enough fiber: While the recommended total dietary intake of fiber is 25 to 30 grams per day, adults average about 15 grams per day, per UCSF Health, so eating oranges can help fill that gap.

3. Oranges Are Tied to a Healthy Immune System

Perhaps most famously associated with vitamin C, oranges can help keep your immune system functioning at its best.

That said, vitamin C is not a cure-all or sure bet for preventing the common cold (or other illnesses). Only extremely active people like marathon runners and skiers who took at least 200 milligrams of vitamin C daily (about the amount in two oranges) appeared to cut their chances of getting a common cold in half in a January 2013 review published in the Cochrane Database of Systematic Reviews.

The same effect wasn't seen for the general population. However, taking at least 200 milligrams daily vitamin C did appear to shorten the duration of cold symptoms by an average of 8 percent in adults and 14 percent in children which equates to about one day less of sickness according to Harvard Medical School.

When possible, it's best to get nutrients like vitamin C from food rather than supplements. People with high intakes of vitamin C from fruits and vegetables might have a lower risk of getting several types of cancer, including lung, colon and breast cancer, per the National Institutes of Health (NIH). Vitamin C supplements don't appear to have the same protective effect.

People who eat many fruits and vegetables also appear to have a lower risk of heart disease, which may be due to antioxidants that stave off oxidative damage, a major cause of heart disease. More research is needed to determine if vitamin C plays a role in this protective effect and if it can slow down the progression of heart disease and those who already have it.

Fruits, like oranges, and vegetables are the best sources of vitamin C. Although most people in the U.S. get enough vitamin C from foods and beverages, people who smoke or are exposed to secondhand smoke may not, per the NIH. Smokers need 35 milligrams more vitamin C daily than nonsmokers, partly because smoke increases how much vitamin C your body needs to repair free radical damage.

Orange juice is not necessarily unhealthy in moderation, but whole fruit has far more health benefits. I always recommend the whole fruit over juice, because youll get more fiber than you would in the juice, Allen says.

Half a cup of juice is a serving, which isnt very much. You might end up drinking two to three servings of juice, which is a lot more calories and sugar than you would get from an orange.

While eating whole fruits was associated with a lower risk of type 2 diabetes, a greater intake of fruit juice was associated with a higher risk in an August 2013 _BMJ _study. If you like orange juice, opt for a calcium-fortified variety and dilute it with seltzer water.

Orange Health Risks

Although rare, citrus allergy has been reported with oranges, mandarins and grapefruits, per the American Academy of Allergy, Asthma & Immunology (AAAAI).

Many people with fruit allergy are sensitized to pollen and may react to a number of other fruits, according to the University of Nebraska-Lincoln Food Allergy and Resource Program. About 39 percent of children and young adults with hay fever also had a sensitivity to citrus fruits in a small January 2013 study of 72 participants published in the journal PLOS One.

Citric acid, a chemical naturally found in citrus fruits but also used as an additive in foods, does not provoke an immune response including in people with citrus allergy, according to the AAAAI.

It's important to speak to an allergist if you suspect you have a food allergy, which can cause symptoms such as vomiting, hives, shortness of breath or even life-threatening anaphylaxis. If you have a food allergy, you may need to carry epinephrine with you at all times in case of a severe reaction.

Oranges have potassium, which helps send electrical signals to heart-muscle cells and other cells. Avoid consuming them with ACE inhibitors such as:

These medications are used to lower blood pressure or treat heart failure and could increase levels of potassium in your body when combined with oranges (which contain potassium), per Consumer Reports. This may lead to heart palpitations or irregular heartbeat, which can be fatal.

For the same reason, you should avoid mixing oranges with some diuretics like triamterene (Dyrenium), used to lower fluid retention and treat high blood pressure.

Seville oranges (bitter oranges), which are often used in orange marmalade, can affect the same enzyme as grapefruit juice so it's best to avoid them if your medication reacts with grapefruit juice, per the U.S. Food & Drug Administration (FDA).

Depending on the active ingredient, grapefruit can lower the effectiveness of a drug or cause dangerous drug levels in the body by interfering with transporters in the intestine. Ask your doctor if you can have fresh grapefruit juice while on your medication (and if not, avoid Seville oranges).

Currently there are more than 50 prescription and over-the-counter drugs known to have negative interactions with grapefruit.

Orange Preparation and Helpful Tips

In the U.S., most oranges are grown in California, Florida and Texas, and can be found in supermarkets year-round. Follow these tips to incorporate oranges into your diet.

Check oranges before buying. You should be able to squeeze a fresh orange slightly, and its orange hue should predominate over green, according to the USDA.

Oranges vary in characteristics by type. For instance, navel oranges are easy to peel and don't have seeds. Valencia oranges do have seeds and are more difficult to peel, but are generally less expensive than navel oranges.

Wash oranges before using them. The USDA recommends washing oranges under cold, running water before peeling them. If you're using the skin for zest, scrub the orange peel with a vegetable brush.

Slice easily and store properly. Place the orange on its side, with the stem ends between your hands, then carefully cut into wedges. This makes it easy to remove the wedges from the skin, per the USDA.

Florida and Texas oranges are best stored at 32 to 34 degrees Fahrenheit, while California oranges are ideally stored at 38 to 48 degrees Fahrenheit. Refrigerated oranges have a shelf life of about 10 days. For a refreshing treat, freeze orange wedges for up to one hour.

Alternatives to Oranges

Oranges provide a range of healthy nutrients that can benefit your skin, digestive health and immune system. They're packed with vitamin C, and provide 18 percent of the daily value of fiber. As such, they're considered a heart-healthy addition to your diet.

Citrus fruits are similar in nutritional value. You can replace oranges for other fruits such as grapefruit and tangerines for similar health benefits.

See more here:
Orange Nutrition: Benefits, Calories, Warnings and Recipes - LIVESTRONG.COM

Posted in Nebraska Stem Cells | Comments Off on Orange Nutrition: Benefits, Calories, Warnings and Recipes – LIVESTRONG.COM

CO2 Incubators Market is Expected to Witness a Steady Growth by 2025 – Farmers Ledger

Posted: June 4, 2020 at 9:26 am

Keep yourself up-to-date with latest market trends and maintain a competitive edge by sizing up with available business opportunity in Global CO2 Incubators Market various segments and emerging territory. The research report presents a comprehensive assessment of the Global CO2 Incubators Market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and competition landscapes.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/3431-global-co2-incubators-market-2

What is CO2 Incubators?

CO2 Incubator is a device which is used to grow and maintain the tissue culture cell under a CO2 atmosphere. These incubators also maintain the natural environment with optimal humidity, temperature, and other conditions. Typical temperature settings range is from 4C to 50C, CO2 concentrations run from 0.3 to 19.9% and relative humidity of about 95 percent in these CO2 incubators and have a PH of 7.2 to 7.5. These incubators are most commonly used in biology labs to perform tissue culture or cell development and are used in any process where both bacterial, as well as eukaryotic cells, need to be cultured for a few hours or many weeks or where cells need to be expanded or maintained. These are one of the most widely used incubators in any cell culturing laboratory environment. The global carbon dioxide incubator market is expected to witness significant growth during the forecast period by increasing the number of applications of carbon dioxide incubators such as cancer research, embryonic cell research, stem cell research, neuroscience, tissue engineering and cultivation of mammalian cells.

Important Features that are under offering & key highlights of the CO2 Incubators market report:

> The study is conducted by collecting data of various companies from the industry, and the base for coverage is NAICS standards. However, the study is not limited to profile only few companies. Currently the research report is listed with players like Thermo Scientific (United States), Eppendorf (Germany), Panasonic Healthcare Co (Japan), Binder (United States), NuAire (United States), LEEC (United Kingdom), ESCO (United States), Memmert (India), Caron (United States) and Sheldon Manufacturing (United States)

> In the premium version of report, two-level of regional segmentation allows user to have access to country level break-up of market Size by revenue and volume* Additionally it also highlights how local reforms have made impact in the country and how business segments are performing or may perform in future.

* Wherever applicable

> Yes, for a deep dive we do provide add-on segmentation in premium version of report to better derive market values. The standard version of this report covers segmentation by Application, by Type and by Regions and players

The Global CO2 Incubators segments and Market Data Break Down are illuminated below:

by Type (Water Jacketed CO2 Incubators, Air-Jacketed CO2 Incubators, Direct Heat CO2 Incubators), Application (Industrial, Biotechnology, Agriculture, Others), Capacity Type (Below 100L, Above 100L & Below 200L, Above 200L)

Analytical Market Highlights & Approach:

The Global CO2 Incubators Market report provides the rigorously studied and evaluated data of the top industry players and their scope in the market by means of several analytical tools. The analytical tools such as Porters five forces analysis, feasibility study, SWOT analysis, and ROI analysis have been practiced reviewing the growth & operational efficiency of the key players operating in the market.

Enquire for customization in Report @:https://www.advancemarketanalytics.com/enquiry-before-buy/3431-global-co2-incubators-market-2

What benefits does AMA research studies provides:

On the basis of geographical regions, the Global CO2 Incubators Market is segmented broadly into Latin America, Europe, the Middle East and Africa, and Asia Pacific. The global market is still in its exploratory stage in most of the regions but it holds the promising potential to flourish steadily in coming years. The major companies investing in this market are situated in Canada, U.K., and the US, India, China and some more countries of Asia Pacific region. Consequently, Asia Pacific, North America, and Western Europe are estimated to hold more than half of the market shares, collectively in coming years.

Table of Content

Global CO2 Incubators Market Research Report

Chapter 1: Global CO2 Incubators Market Overview

Chapter 2: Global Economic Impact on Industry (COVID Impact Analysis, Local Reforms etc)

Chapter 3: Global Market Competition by Manufacturers

Chapter 4: Global Revenue (Value) , Supplies (Production), Consumption, Export, Import by Regions (2014-2025)

Chapter 5: Global Revenue (Value), volume, Price Trend by Type (2014-2025)

Chapter 7: Global Market Analysis by Application (2014-2025)

Chapter 8: Manufacturing Cost Analysis, Benchmarking (2019)

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

.

Read the Latest Detailed Report @https://www.advancemarketanalytics.com/reports/3431-global-co2-incubators-market-2

Key questions answered

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article, we can also provide customized report as per companys specific needs. You can also get separate chapter wise or region wise report versions including North America, Middle East & North Africa (MENA), Europe or Southeast Asia, Asia-Pacific.

About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA 08837

Phone: +1 (206) 317 1218

[emailprotected]

Connect with us atLinkedIn|Facebook|Twitter

Read more here:
CO2 Incubators Market is Expected to Witness a Steady Growth by 2025 - Farmers Ledger

Posted in New Jersey Stem Cells | Comments Off on CO2 Incubators Market is Expected to Witness a Steady Growth by 2025 – Farmers Ledger

Stem Cell Assay Market to Witness Growth Acceleration During 2017-2025 – Cole of Duty

Posted: June 4, 2020 at 9:24 am

Stem Cell Assay Market: Snapshot

Stem cell assay refers to the procedure of measuring the potency of antineoplastic drugs, on the basis of their capability of retarding the growth of human tumor cells. The assay consists of qualitative or quantitative analysis or testing of affected tissues andtumors, wherein their toxicity, impurity, and other aspects are studied.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=40

With the growing number of successfulstem cell therapytreatment cases, the global market for stem cell assays will gain substantial momentum. A number of research and development projects are lending a hand to the growth of the market. For instance, the University of Washingtons Institute for Stem Cell and Regenerative Medicine (ISCRM) has attempted to manipulate stem cells to heal eye, kidney, and heart injuries. A number of diseases such as Alzheimers, spinal cord injury, Parkinsons, diabetes, stroke, retinal disease, cancer, rheumatoid arthritis, and neurological diseases can be successfully treated via stem cell therapy. Therefore, stem cell assays will exhibit growing demand.

Another key development in the stem cell assay market is the development of innovative stem cell therapies. In April 2017, for instance, the first participant in an innovative clinical trial at the University of Wisconsin School of Medicine and Public Health was successfully treated with stem cell therapy. CardiAMP, the investigational therapy, has been designed to direct a large dose of the patients own bone-marrow cells to the point of cardiac injury, stimulating the natural healing response of the body.

Newer areas of application in medicine are being explored constantly. Consequently, stem cell assays are likely to play a key role in the formulation of treatments of a number of diseases.

Global Stem Cell Assay Market: Overview

The increasing investment in research and development of novel therapeutics owing to the rising incidence of chronic diseases has led to immense growth in the global stem cell assay market. In the next couple of years, the market is expected to spawn into a multi-billion dollar industry as healthcare sector and governments around the world increase their research spending.

The report analyzes the prevalent opportunities for the markets growth and those that companies should capitalize in the near future to strengthen their position in the market. It presents insights into the growth drivers and lists down the major restraints. Additionally, the report gauges the effect of Porters five forces on the overall stem cell assay market.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=40<ype=S

Global Stem Cell Assay Market: Key Market Segments

For the purpose of the study, the report segments the global stem cell assay market based on various parameters. For instance, in terms of assay type, the market can be segmented into isolation and purification, viability, cell identification, differentiation, proliferation, apoptosis, and function. By kit, the market can be bifurcated into human embryonic stem cell kits and adult stem cell kits. Based on instruments, flow cytometer, cell imaging systems, automated cell counter, and micro electrode arrays could be the key market segments.

In terms of application, the market can be segmented into drug discovery and development, clinical research, and regenerative medicine and therapy. The growth witnessed across the aforementioned application segments will be influenced by the increasing incidence of chronic ailments which will translate into the rising demand for regenerative medicines. Finally, based on end users, research institutes and industry research constitute the key market segments.

The report includes a detailed assessment of the various factors influencing the markets expansion across its key segments. The ones holding the most lucrative prospects are analyzed, and the factors restraining its trajectory across key segments are also discussed at length.

Global Stem Cell Assay Market: Regional Analysis

Regionally, the market is expected to witness heightened demand in the developed countries across Europe and North America. The increasing incidence of chronic ailments and the subsequently expanding patient population are the chief drivers of the stem cell assay market in North America. Besides this, the market is also expected to witness lucrative opportunities in Asia Pacific and Rest of the World.

Global Stem Cell Assay Market: Vendor Landscape

A major inclusion in the report is the detailed assessment of the markets vendor landscape. For the purpose of the study the report therefore profiles some of the leading players having influence on the overall market dynamics. It also conducts SWOT analysis to study the strengths and weaknesses of the companies profiled and identify threats and opportunities that these enterprises are forecast to witness over the course of the reports forecast period.

Some of the most prominent enterprises operating in the global stem cell assay market are Bio-Rad Laboratories, Inc (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.K.), Hemogenix Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), STEMCELL Technologies Inc. (CA), Cell Biolabs, Inc. (U.S.), and Cellular Dynamics International, Inc. (U.S.).

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=40

About Us:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Follow this link:
Stem Cell Assay Market to Witness Growth Acceleration During 2017-2025 - Cole of Duty

Posted in Wisconsin Stem Cells | Comments Off on Stem Cell Assay Market to Witness Growth Acceleration During 2017-2025 – Cole of Duty

Canine Stem Cell Therapy Market Will Make a Huge Impact in Near Future – Cole of Duty

Posted: June 4, 2020 at 9:21 am

A synopsis of the global canine stem cell therapy market with reference to the global healthcare pharmaceutical industry

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare Current expenditure on health, % of gross domestic product Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs) Annual growth rate of current expenditure on health, per capita, in real terms Out-of-pocket expenditure, % of current expenditure on health Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs) Physicians, Density per 1000 population (head counts) Nurses, Density per 1000 population (head counts) Total hospital beds, per 1000 population Curative (acute) care beds, per 1000 population Medical technology, Magnetic Resonance Imaging units, total, per million population Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

Get Sample Copy of this report at https://www.xploremr.com/connectus/sample/2360

XploreMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Browse Full Report at https://www.xploremr.com/report/2360/canine-stem-cell-therapy-market

Standard Report Structure Executive Summary Market Definition Macro-economic analysis Parent Market Analysis Market Overview Forecast Factors Segmental Analysis and Forecast Regional Analysis Competition Analysis

Target Audience Production Companies Suppliers Channel Partners Marketing Authorities Subject Matter Experts Research Institutions Financial Institutions Market Consultants Government Authorities

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type: Allogeneic Stem Cells Autologous Stem cells

Application: Arthritis Dysplasia Tendonitis Lameness Others

End User: Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

Region: North America Latin America Europe Asia Pacific Japan Middle East & Africa

Buy Full Report at https://www.xploremr.com/cart/2360/SL

About Us

XploreMR is one of the worlds leading resellers of high-quality market research reports. We feature in-depth reports from some of the worlds most reputed market research companies and international organizations. We serve across a broad spectrum from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.

Contact us:XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108

Go here to see the original:
Canine Stem Cell Therapy Market Will Make a Huge Impact in Near Future - Cole of Duty

Posted in Stem Cell Therapy | Comments Off on Canine Stem Cell Therapy Market Will Make a Huge Impact in Near Future – Cole of Duty

Stem Cell Therapy Market Comprehensive Analysis, Growth Forecast From 2019 To 2025 – Cole of Duty

Posted: June 4, 2020 at 9:21 am

The Stem Cell Therapy Market report has been evaluated with respect to vital aspects such as Industry Strategies, Evolving Technology, Growth rate, Key Companies, Business Competitors, and Forecast till 2025. Substantial details highlighting the importance of the most significant sectors of this business are included in the study.

The Stem Cell Therapy Market is anticipated to record its name in the billion-dollar space within seven years, by exceeding revenue of US$ 15 billion by 2025, with an anticipated CAGR of 10.2% through 2025.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3331

The Stem Cell Therapy Market report delivers a concise analysis pertaining to the competitive landscape of this industry. All the vital information with regards to this parameter have been covered in the report in a systematic manner. The overall summary has been included after conducting a detailed analysis of the driving parameters, the factors that may hamper the market growth, as well as the growth prospects that this business space has in the future.

Market Segmentation:

Know about Market growth in New Research and its Top growing factors by Key Companies like

Astellas Pharma Inc, Capricor Therapeutics, Cellectis, Cellular Dynamics, Celyad, CESCA Therapeutic, DiscGenics, Gamida Cell, Mesoblast Ltd, Novadip Biosciences, OxStem, ReNeuron Group plc, Takeda Pharmaceuticals

Comprehensive Review of Market Growth, Applications, and Future Prospects

The Regional Evaluation Ensures

Make an inquiry for purchasing this [emailprotected] https://www.gminsights.com/inquiry-before-buying/3331

The Stem Cell Therapy Market research report presents a detailed outline of Stem Cell Therapy Market this is mainly inclusive of the generic market definitions, the numerous segmentations, as well as the application landscape. The report outlines a detailed examination of the industry vendors from a regional and global perspective.

An exhaustive brief of the various forecast trends and demand till the year 2025 has been given in the report. The study is inclusive of information pertaining to the numerous firms that form a part of the competitive terrain of this business sphere. Also, the report contains, in exclusive detail, information on the many innovations in this sector, technologies adopted, and also many other factors impacting the product demand.

Report Growth Drivers

Request for discount @ https://www.gminsights.com/request-discount/3331

The Stem Cell Therapy Market Report Includes

Continued here:
Stem Cell Therapy Market Comprehensive Analysis, Growth Forecast From 2019 To 2025 - Cole of Duty

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy Market Comprehensive Analysis, Growth Forecast From 2019 To 2025 – Cole of Duty

CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases | DNA RNA and Cells |…

Posted: June 4, 2020 at 9:17 am

DetailsCategory: DNA RNA and CellsPublished on Wednesday, 03 June 2020 09:39Hits: 523

Initially, the alliance will develop treatment options for patients with two rare, life-threatening primary immunodeficiency diseases -- Wiskott-Aldrich Syndrome (WAS) and X-linked Agammaglobulinemia (XLA)

SEATTLE, WA and KING of PRUSSIA, PA, USA I June 2, 2020 I Seattle Children's Research Institute, one of the top pediatric research institutions in the world, and global biotechnology leader CSL Behring announced a strategic alliance to develop stem cell gene therapies for primary immunodeficiency diseases.

Initially, the alliance will focus on the development of treatment options for patients with two rare, life-threatening primary immunodeficiency diseases -- Wiskott-Aldrich Syndrome and X-linked Agammaglobulinemia. These are two of more than 400 identified primary immunodeficiency diseases in which a part of the body's immune system is missing or functions improperly.

"CSL Behring will collaborate with Seattle Children's experts to apply our novel gene therapy technology to their research pipeline, with an aim to address unmet needs for people living with certain rare primary immunodeficiency diseases," said Bill Mezzanotte, MD, Executive Vice President, Head of Research and Development for CSL Behring. "Expanding our gene therapy portfolio into an area of immunology well known to CSL exemplifies how we are strategically growing our capabilities in this strategic scientific platform and are collaborating with world class institutions to access innovation with the potential to vastly improve patients' lives."

"Stem cell gene therapies that correct the genetic abnormality driving a child's disease will transform the therapeutic options for children with Wiskott-Aldrich Syndrome, X-Linked Agammaglobulinemia and other immunodeficiency diseases,"said David J. Rawlings, MD, director of the Center for Immunity and Immunotherapies and division chief of immunology at Seattle Children's, and a professor of pediatrics and immunology at the University of Washington School of Medicine."The collaboration with CSL Behring supports our longstanding research programs for pediatric immunodeficiency diseases and will accelerate this research toward clinical trials, helping get these innovations to the children who need them."

CSL Behring researchers, working with researchers from Seattle Children's Research Institute, will investigate applying the proprietary platform technologies, Select+ and Cytegrity, to several pre-clinical gene therapy programs. These technologies, which have broad applications in ex vivo stem cell gene therapy, are designed to address some of the major challenges associated with the commercialization of stem cell therapy, including the ability to manufacture consistent, high-quality products, and to improve engraftment, efficacy and tolerability.

Wiskott-Aldrich Syndrome (WAS) has an estimated incidence between one and 10 cases per million males worldwide, according to the National Institutes of Health. WAS patients' immune systems function abnormally, making them susceptible to infections. They also experience eczema, autoimmunity and difficulty forming blood clots, leaving them vulnerable to life threatening bleeding complications. Today the only knowncurefor WAS is a stem cell transplant, if a suitable donor can be found.

X-linked Agammaglobulinemia (XLA) is another rare primary immunodeficiency in which patients have low levels of immunoglobulins (also known as antibodies), which are key proteins made by the immune system to help fight infections. Like WAS, XLA affects males almost exclusively, although females can be genetic carriers of the condition. While no cure exists for XLA, the goal of treatment is to boost the immune system by replacing missing antibodies and preventing or aggressively treating infections that occur, according to the Immune Deficiency Foundation.

About Seattle Children's

Seattle Children's mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children's Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.

Ranked as one of the top children's hospitals in the country by U.S. News & World Report, Seattle Children's serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho the largest region of any children's hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children's Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children's Hospital and Research Foundation works with the Seattle Children's Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research. Join Seattle Children's bold initiative It Starts With Yes: The Campaign for Seattle Children's to transform children's health for generations to come.

For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients' needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company's products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL;USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 26,000 people, and delivers its life-saving therapies to people in more than 70 countries. For more information, visit http://www.cslbehring.com and for inspiring stories about the promise of biotechnology, visit Vita http://www.cslbehring.com/Vita.

SOURCE: CSL Behring

More here:
CSL Behring and Seattle Children's Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases | DNA RNA and Cells |...

Posted in Idaho Stem Cells | Comments Off on CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases | DNA RNA and Cells |…

Page 990«..1020..989990991992..1,0001,010..»